Peter Radovich - 10 Nov 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Operating Officer
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 Nov 2022
Net transactions value
+$4,979
Form type
4
Filing time
14 Nov 2022, 20:41:31 UTC
Previous filing
19 Aug 2022
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $4,979 +292 +1.2% $17.05 23,692 10 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 292 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.